<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> accompanied by hematopathy under granulocytopenic conditions were treated with <z:chebi fb="0" ids="3489">cefmetazole</z:chebi> (<z:chebi fb="1" ids="3490">CMZ</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>Subject diseases mainly consisted of <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, <z:mp ids='MP_0000334'>agranulocytosis</z:mp> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>; combined <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> were <z:mpath ids='MPATH_681'>septicemia</z:mpath>, <z:hpo ids='HP_0002090'>pneumonia</z:hpo>, <z:hpo ids='HP_0001945'>fever</z:hpo> of an undetermined origin, etc </plain></SENT>
<SENT sid="2" pm="."><plain>As for causative organisms found in cases that could be examined, <z:mp ids='MP_0001795'>Gram-negative</z:mp> bacilli such as Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa and Enterobacter cloacae were isolated, as was Staphylococcus aureus </plain></SENT>
<SENT sid="3" pm="."><plain>In general, 4 g of <z:chebi fb="1" ids="3490">CMZ</z:chebi> divided into 2 administrations was given per day through intravenous injection or intravenous drip infusion </plain></SENT>
<SENT sid="4" pm="."><plain>On the basis of the judgement criteria for effectiveness established by Takaku et al., the efficacy rate in this study was found to be 68%, including 2 cases that showed excellent responses to treatment of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> caused by S. aureus </plain></SENT>
<SENT sid="5" pm="."><plain>Cases that showed pyretolysis within 4 days had over 1,000/microliter of neutrophils, while cases with less than 1,000/microliter showed no pyretolysis </plain></SENT>
<SENT sid="6" pm="."><plain>No hepatorenal dysfunctions related to the treatment with <z:chebi fb="1" ids="3490">CMZ</z:chebi> were seen as side effects except increases of transaminase in 1 case </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that <z:chebi fb="1" ids="3490">CMZ</z:chebi> is a useful drug for the treatment of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> accompanied by hematopathy under granulocytopenic condition </plain></SENT>
</text></document>